Ingaruka Ziburyohe za Retatrutide: Ibyo Ubushakashatsi bwakorewe mu Bitaro Bivuze Kugeza Ubu

Ingaruka ziburyohe za retatrutide zikunze kugaragara ni ibibazo byo mu gifu nko kuruka, impiswi, kwituma cyane, n'umutwe. Izi ni zimwe na zimwe abantu bahura nazo n'imiti nk'iya GLP-1 nka semaglutide na tirzepatide. Zikunda kugaragara hakiri kare mu kuvura, cyane cyane mugihe habaho kongera urugero, kandi abenshi babona ko zigabanuka igihe umubiri ubimenyera.

Retatrutide ni uruvange rugikorerwaho ubushakashatsi. Ntarahabwa uruhushya na FDA kandi ubu iri mu bushakashatsi bwa rwego rwa 3. Bityo rero, ibyo twese tuzi kuri ingaruka zacyo biva mu makuru yakusanyijwe mu bushakashatsi. Ariko hari ingano nziza y'amakuru yo kwitegereza, harimo ibisubizo bivuye mu bushakashatsi bwa rwego rwa 3 bwaherutse bise TRIUMPH-4.

Ni Izihe Ngaruka Zikunze Kugaragara?

Urugero rw'ibinyobwa rugaragaraho ingaruka nyinshi, nibura mu ntangiriro. Ibi birumvikana kuko retatrutide ikora yifashishije imisemburo itatu (GLP-1, GIP, na glucagon) itera imbaraga ku kurya, imikorere y'igifu, n'igihe igifu cyuzura.

Mu bushakashatsi bwa rwego rwa 3 bwa TRIUMPH-4, bwakoresheje urugero rwo hejuru cyane (9 mg na 12 mg) ku bantu bakuru 445, ingaruka zikunze kuvugwa kuri 12 mg ugereranyije na placebo zari:

• Kuruka (43.2% ugereranyije na 10.7% kuri placebo)
• Impiswi (33.1% ugereranyije na 13.4% kuri placebo)
• Kwituma cyane (25.0% ugereranyije na 8.7% kuri placebo)
• Kwiruka (20.9% ugereranyije na 0.0% kuri placebo)
• Kugabanuka kw'icurabura (18.2% ugereranyije na 9.4% kuri placebo)

Urugero rwa 9 mg rwagaragaje ibipimo biringaniye kugeza hasi. Ibi bipimo biruta cyane ibyo usanga mu gihe cyose ufata semaglutide cyangwa tirzepatide, ibi bikaba bisanzwe kuko retatrutide ari imiti ifite imbaraga zikubye inshuro eshatu. Ariko imiterere irasa. Izi ni zimwe na zimwe ingaruka zigaragara ku miti yose y'uruhererekane.

Icy'ingenzi cyo kumenya ni uko izi ngaruka nyinshi zagaragaye nk'ibintu bikeya kugeza ku byoroheje. Byagaragaye cyane mu cyumweru cya mbere cy'ivurwa n'igihe habaho kongera urugero, hanyuma bigahinduka gahoro gahoro igihe abitabiriye bagumaga ku rugero rumwe.

[IMG:https://assets.getbeyondhealth.com/health-lib/blogs/manual_upload_20260216024926_retatrutide-side-eff.png]

Ese Retatrutide Yagira Ingaruka Ku Muyoboro W'umutima?

Ni ikintu abashakashatsi bakomeje kwitegereza. Mu bushakashatsi bwa rwego rwa 2, bamwe mu bitabiriye mu rugero rwo hejuru bagize kwiyongera gato ku muyoboro w'umutima utaruhutse, ku ishusho ya buri munsi, bafite iminota 5 kugeza 7.

Abaro bacye kandi bagize impinduka nto mu ruririmbo rw'umutima. Ariko, nta kwiyongera kw'impanuka z'umutima cyangwa ibibazo bikomeye byagaragaye mu bushakashatsi bwa retatrutide kugeza ubu. Ahubwo, abitabiriye bagize impinduka nziza mu musingi wa demokarasi, cholesterol, n'ibindi bimenyetso by'umutima. Mu bushakashatsi bwa TRIUMPH-4, urugero rwa 12 mg rwagabanyije umusatsi wa demokarasi ku ishusho ya mmHg 14.

Bityo, nubwo kwiyongera gato ku muyoboro w'umutima bifite agaciro ko kwitonderwa, ishusho rusange y'umutima iragaragara neza hashingiwe ku byo tuzi uyu munsi.

Ni Ikihe Gihamya Cy'ikibazo Cy'ububabare Ku Ruhago?

Iki ni ikintu gishya cyagaragaye mu bushakashatsi bwa rwego rwa 3 bwa TRIUMPH-4. Dysesthesia ni ibyiyumvo bidasanzwe cyangwa bidashimishije ku ruhu, rimwe na rimwe bivugwa nk'ububabare, kubura ubwenge, cyangwa ububabare bwo gutwikwa. Byagaragaye ku 8.8% by'abitabiriye mu rugero rwa 9 mg na 20.9% mu rugero rwa 12 mg, ugereranyije na 0.7% gusa kuri placebo.

Iyi ngaruka ntiyagaragaye mu bushakashatsi bwa mbere bwa rwego rwa 2, bityo ni ikintu gishya cyane abasesenguzi n'abashakashatsi bakomeje gutegereza. Eli Lilly yasobanuye ko ibibazo byari byoroheje, kandi ko byajyaga bitera abantu kutavura. Ariko hamwe n'ibindi bisubizo birindwi byo mu bushakashatsi bwa rwego rwa 3 byitezwe muri 2026, iki kizakomeza kurebwamo kugira ngo hamenyekane uko cyakomeza kandi niba kizamara igihe.

Ese Hari Ingaruka Zikomeye?

Ingaruka zikomeye za retatrutide ntizikunze kugaragara mu bushakashatsi kugeza ubu. Ariko ibibazo bimwe bishobora kubaho kuko byagaragaye ku miti ya GLP-1.

Dore ibyo abashakashatsi bakomeje kwitegereza:

• Gukama kw'umwijima (inflammation of the pancreas) byagaragaye rimwe na rimwe ku miti ya GLP-1. Nta miburanishwa yemejwe y'ibyo byagaragaye kuri retatrutide, ariko ni ikintu abaganga bakomeje kwitegereza. Ibimenyetso ni kubabara bikomeye mu nda bishobora kujya ku mugongo.
• Ibikorwa by'umwijima, harimo amabuye y'umwijima, byahujwe no kugabanuka cyane kw'ibiro n'imiti ya incretin. Ubushakashatsi burimo no kugenzura ibi kuri retatrutide.
• Hypoglycemia (kugabanuka cyane kwa sukari mu maraso) ntibyari ikibazo gikomeye mu bushakashatsi. Nta miburanishwa ya hypoglycemia ikomeye yagaragaye, ibi bikaba birashimishije.
• Imikorere y'umwijima n'impyiko byagenzuwe mu bushakashatsi, kandi nta ngaruka zikomeye zagaragaye muri izo nzego.

Ni ngombwa kuvuga ko nta rupfu rwahujwe na retatrutide mu makuru yakwirakwijwe kugeza ubu.

Ni Abantu Bangahe Bagaruye Kuvura Kubera Ingaruka Ziburyohe?

Mu bushakashatsi bwa TRIUMPH-4, ingaruka zo guhagarika kuvurwa kubera ibibazo byari 12.2% mu rugero rwa 9 mg na 18.2% mu rugero rwa 12 mg, ugereranyije na 4% kuri placebo. Bamwe muri abo bahagaritswe byari kubera ko Lilly ivuga ko "kwagabanuka k'uburemere burenze," atari kubera ko bumvise barwaye.

Igihe abashakashatsi barebaga gusa abafite BMI ya 35 cyangwa hejuru (bishobora kuba ubwinshi bukabije), ingaruka zo guhagarika kuvurwa zigabanuka zikaba 8.8% na 12.1% ku rugero rw'ibiri. Ibi byerekana ko abafite uburemere buruta ku ntangiriro bashobora kwihanganira imiti neza, ahari kuko imirimo yo kugabanuka kw'ibiro ibatera ibyiyumvo byoroheje.

[IMG:https://assets.getbeyondhealth.com/health-lib/blogs/manual_upload_20260216024317_retatrutide-side.png]

Kuki Kugabana Urugero Gahoro Bihagije?

Ubushakashatsi bwa retatrutide bukoresha uburyo bwo kugabana urugero bw'intambwe kubw'impamvu. Abitabiriye batangira ku rugero ruto rwa 2 mg kandi bakiyongeraho buri cyumweru kugera bahuye n'urugero bashaka. Uku kwiyongera gahoro guha umubiri igihe cyo kwimenyera buri ntambwe mbere yo kujya ku ikurikira.

Ubu buryo ni bwo bwonyine bufite ingaruka zikomeye zo kugabanya ingaruka ziburyohe. Kwijira mu rugero rwo hejuru cyane byakongera cyane ibibazo byo kuruka, kwituma cyane, n'ibindi bibazo byo mu gifu. Uku kwiyongera gahoro ni nako kamaro kuko **abenshi mu bitabiriye babonye ko ingaruka zabo za mbere zagabanutse mu minsi 8 kugeza 12 y'uko bagumye ku rugero rumwe.**

Ni Iki Tutazi Kugeza Ubu?

Kuko retatrutide yagenzuwe gusa kugeza ku minsi 68 mu bushakashatsi bwayo bwerehereye, amakuru yerekeranye n'umutekano w'igihe kirekire uy'umwaka iracyari mike. Ntituzi igihe cyose uko ingaruka z'uburyohe zisasa kugeza ku myaka ibiri, itanu, cyangwa icumi yo gukoresha. Ib daz'igenera ku kuba umusatsi ugabanuka, ubuzima bw'amagufwa, ubwinshi bw'imikino, n'ubuzima bw'umuhogo bikomeje kuba bibazwa kugeza ubushakashatsi bwerekeje bwahaye ibisubizo.

Eli Lilly ifite ibindi bisubizo birindwi byo mu bushakashatsi bwa rwego rwa 3 byitezwe muri 2026, byibanda ku bw'ububare, diyabete yo mu rwego rwa 2, ibibazo by'ibitotsi, indwara z'umwijima, kubabara kw'umugongo, n'imibereho y'umutima. Ubwo bushakashatsi buzaha ishusho yuzuye neza y'inyungu n'ibinyabuzima.

Niba retatrutide izabona uruhushya rwa FDA, muganga wawe azashobora kukuyobora mu kureba niba ingaruka z'uburyohe zikwiriye ku bihe byawe. Ubu, amakuru agaragaza imiti ifite ibisubizo byo kugabanuka k'uburemere kandi ingaruka z'uburyohe zikaba zoroheye abenshi, cyane cyane hamwe no kugabana urugero witonze.